Disseminated Intravascular Coagulation Diagnosis Market, Global Outlook and Forecast 2023-2029

Report ID: MMG194198 | Category: Medical Devices & Consumables | Pages: 61 | Format: PDF | Published Date: September 04,2023

Request Sample Enquiry before buying Ask For Discount

Single User-$3250.00 Multi User-$4225.00

Report Description
View Table of Contents

Report Summary

Disseminated intravascular coagulation (DIC) is a rare but serious condition that causes abnormal blood clotting throughout the body's blood vessels. You may develop DIC if you have an infection or injury that affects the body's normal blood clotting process.DIC is an acquired clinic biological syndrome characterized by widespread coagulation activation, which results in fibrin deposition in the vasculature, organ dysfunction, clotting factor and platelet consumption, and life-threatening hemorrhage. Several underlying disorders can cause disseminated intravascular coagulation (sepsis, cancer, trauma, and pregnancy complicated with eclampsia or other calamities). The cornerstone therapeutic approaches are treating the underlying disease and eliminating the trigger mechanism. DIC-specific therapeutic strategies aim to reduce blood coagulation activation and bleeding risk. Few clinical trials use DIC as an entry criterion.
This report aims to provide a comprehensive presentation of the global market for Disseminated Intravascular Coagulation Diagnosis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Disseminated Intravascular Coagulation Diagnosis. This report contains market size and forecasts of Disseminated Intravascular Coagulation Diagnosis in global, including the following market information:
Global Disseminated Intravascular Coagulation Diagnosis Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Disseminated Intravascular Coagulation Diagnosis market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Complete Blood Count with Blood Smear Exam Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Disseminated Intravascular Coagulation Diagnosis include Abbott, AdvaCare Pharma, Axis-Shield Diagnostics, QuidelOrtho, CTK Biotech, AccuBioTech Co, Getein Biotech, PHC Holdings Corporation and Siemens Healthineers, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Disseminated Intravascular Coagulation Diagnosis companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Disseminated Intravascular Coagulation Diagnosis Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Disseminated Intravascular Coagulation Diagnosis Market Segment Percentages, by Type, 2022 (%)
    Complete Blood Count with Blood Smear Exam
    Partial Thromboplastin Time (PTT)
    Prothrombin Time (PT)
    Fibrinogen Blood Test
    D-dimer Test
    Others
Global Disseminated Intravascular Coagulation Diagnosis Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Disseminated Intravascular Coagulation Diagnosis Market Segment Percentages, by Application, 2022 (%)
    Hospital
    Outpatient Center
    Diagnostic and Research Laboratories
    Others
Global Disseminated Intravascular Coagulation Diagnosis Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Disseminated Intravascular Coagulation Diagnosis Market Segment Percentages, By Region and Country, 2022 (%)
    North America
        US
        Canada
        Mexico
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Benelux
        Rest of Europe
    Asia
        China
        Japan
        South Korea
        Southeast Asia
        India
        Rest of Asia
    South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Turkey
        Israel
        Saudi Arabia
        UAE
        Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Disseminated Intravascular Coagulation Diagnosis revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Disseminated Intravascular Coagulation Diagnosis revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
    Abbott
    AdvaCare Pharma
    Axis-Shield Diagnostics
    QuidelOrtho
    CTK Biotech
    AccuBioTech Co
    Getein Biotech
    PHC Holdings Corporation
    Siemens Healthineers
    Eurolyser Diagnostica GmbH
Outline of Major Chapters:
Chapter 1: Introduces the definition of Disseminated Intravascular Coagulation Diagnosis, market overview.
Chapter 2: Global Disseminated Intravascular Coagulation Diagnosis market size in revenue.
Chapter 3: Detailed analysis of Disseminated Intravascular Coagulation Diagnosis company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Disseminated Intravascular Coagulation Diagnosis in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

1 Introduction to Research & Analysis Reports
    1.1 Disseminated Intravascular Coagulation Diagnosis Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Disseminated Intravascular Coagulation Diagnosis Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Disseminated Intravascular Coagulation Diagnosis Overall Market Size
    2.1 Global Disseminated Intravascular Coagulation Diagnosis Market Size: 2022 VS 2029
    2.2 Global Disseminated Intravascular Coagulation Diagnosis Market Size, Prospects & Forecasts: 2018-2029
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Disseminated Intravascular Coagulation Diagnosis Players in Global Market
    3.2 Top Global Disseminated Intravascular Coagulation Diagnosis Companies Ranked by Revenue
    3.3 Global Disseminated Intravascular Coagulation Diagnosis Revenue by Companies
    3.4 Top 3 and Top 5 Disseminated Intravascular Coagulation Diagnosis Companies in Global Market, by Revenue in 2022
    3.5 Global Companies Disseminated Intravascular Coagulation Diagnosis Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Disseminated Intravascular Coagulation Diagnosis Players in Global Market
        3.6.1 List of Global Tier 1 Disseminated Intravascular Coagulation Diagnosis Companies
        3.6.2 List of Global Tier 2 and Tier 3 Disseminated Intravascular Coagulation Diagnosis Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Disseminated Intravascular Coagulation Diagnosis Market Size Markets, 2022 & 2029
        4.1.2 Complete Blood Count with Blood Smear Exam
        4.1.3 Partial Thromboplastin Time (PTT)
        4.1.4 Prothrombin Time (PT)
        4.1.5 Fibrinogen Blood Test
        4.1.6 D-dimer Test
        4.1.7 Others
    4.2 By Type - Global Disseminated Intravascular Coagulation Diagnosis Revenue & Forecasts
        4.2.1 By Type - Global Disseminated Intravascular Coagulation Diagnosis Revenue, 2018-2023
        4.2.2 By Type - Global Disseminated Intravascular Coagulation Diagnosis Revenue, 2024-2029
        4.2.3 By Type - Global Disseminated Intravascular Coagulation Diagnosis Revenue Market Share, 2018-2029
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Disseminated Intravascular Coagulation Diagnosis Market Size, 2022 & 2029
        5.1.2 Hospital
        5.1.3 Outpatient Center
        5.1.4 Diagnostic and Research Laboratories
        5.1.5 Others
    5.2 By Application - Global Disseminated Intravascular Coagulation Diagnosis Revenue & Forecasts
        5.2.1 By Application - Global Disseminated Intravascular Coagulation Diagnosis Revenue, 2018-2023
        5.2.2 By Application - Global Disseminated Intravascular Coagulation Diagnosis Revenue, 2024-2029
        5.2.3 By Application - Global Disseminated Intravascular Coagulation Diagnosis Revenue Market Share, 2018-2029
6 Sights by Region
    6.1 By Region - Global Disseminated Intravascular Coagulation Diagnosis Market Size, 2022 & 2029
    6.2 By Region - Global Disseminated Intravascular Coagulation Diagnosis Revenue & Forecasts
        6.2.1 By Region - Global Disseminated Intravascular Coagulation Diagnosis Revenue, 2018-2023
        6.2.2 By Region - Global Disseminated Intravascular Coagulation Diagnosis Revenue, 2024-2029
        6.2.3 By Region - Global Disseminated Intravascular Coagulation Diagnosis Revenue Market Share, 2018-2029
    6.3 North America
        6.3.1 By Country - North America Disseminated Intravascular Coagulation Diagnosis Revenue, 2018-2029
        6.3.2 US Disseminated Intravascular Coagulation Diagnosis Market Size, 2018-2029
        6.3.3 Canada Disseminated Intravascular Coagulation Diagnosis Market Size, 2018-2029
        6.3.4 Mexico Disseminated Intravascular Coagulation Diagnosis Market Size, 2018-2029
    6.4 Europe
        6.4.1 By Country - Europe Disseminated Intravascular Coagulation Diagnosis Revenue, 2018-2029
        6.4.2 Germany Disseminated Intravascular Coagulation Diagnosis Market Size, 2018-2029
        6.4.3 France Disseminated Intravascular Coagulation Diagnosis Market Size, 2018-2029
        6.4.4 U.K. Disseminated Intravascular Coagulation Diagnosis Market Size, 2018-2029
        6.4.5 Italy Disseminated Intravascular Coagulation Diagnosis Market Size, 2018-2029
        6.4.6 Russia Disseminated Intravascular Coagulation Diagnosis Market Size, 2018-2029
        6.4.7 Nordic Countries Disseminated Intravascular Coagulation Diagnosis Market Size, 2018-2029
        6.4.8 Benelux Disseminated Intravascular Coagulation Diagnosis Market Size, 2018-2029
    6.5 Asia
        6.5.1 By Region - Asia Disseminated Intravascular Coagulation Diagnosis Revenue, 2018-2029
        6.5.2 China Disseminated Intravascular Coagulation Diagnosis Market Size, 2018-2029
        6.5.3 Japan Disseminated Intravascular Coagulation Diagnosis Market Size, 2018-2029
        6.5.4 South Korea Disseminated Intravascular Coagulation Diagnosis Market Size, 2018-2029
        6.5.5 Southeast Asia Disseminated Intravascular Coagulation Diagnosis Market Size, 2018-2029
        6.5.6 India Disseminated Intravascular Coagulation Diagnosis Market Size, 2018-2029
    6.6 South America
        6.6.1 By Country - South America Disseminated Intravascular Coagulation Diagnosis Revenue, 2018-2029
        6.6.2 Brazil Disseminated Intravascular Coagulation Diagnosis Market Size, 2018-2029
        6.6.3 Argentina Disseminated Intravascular Coagulation Diagnosis Market Size, 2018-2029
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Disseminated Intravascular Coagulation Diagnosis Revenue, 2018-2029
        6.7.2 Turkey Disseminated Intravascular Coagulation Diagnosis Market Size, 2018-2029
        6.7.3 Israel Disseminated Intravascular Coagulation Diagnosis Market Size, 2018-2029
        6.7.4 Saudi Arabia Disseminated Intravascular Coagulation Diagnosis Market Size, 2018-2029
        6.7.5 UAE Disseminated Intravascular Coagulation Diagnosis Market Size, 2018-2029
7 Disseminated Intravascular Coagulation Diagnosis Companies Profiles
    7.1 Abbott
        7.1.1 Abbott Company Summary
        7.1.2 Abbott Business Overview
        7.1.3 Abbott Disseminated Intravascular Coagulation Diagnosis Major Product Offerings
        7.1.4 Abbott Disseminated Intravascular Coagulation Diagnosis Revenue in Global Market (2018-2023)
        7.1.5 Abbott Key News & Latest Developments
    7.2 AdvaCare Pharma
        7.2.1 AdvaCare Pharma Company Summary
        7.2.2 AdvaCare Pharma Business Overview
        7.2.3 AdvaCare Pharma Disseminated Intravascular Coagulation Diagnosis Major Product Offerings
        7.2.4 AdvaCare Pharma Disseminated Intravascular Coagulation Diagnosis Revenue in Global Market (2018-2023)
        7.2.5 AdvaCare Pharma Key News & Latest Developments
    7.3 Axis-Shield Diagnostics
        7.3.1 Axis-Shield Diagnostics Company Summary
        7.3.2 Axis-Shield Diagnostics Business Overview
        7.3.3 Axis-Shield Diagnostics Disseminated Intravascular Coagulation Diagnosis Major Product Offerings
        7.3.4 Axis-Shield Diagnostics Disseminated Intravascular Coagulation Diagnosis Revenue in Global Market (2018-2023)
        7.3.5 Axis-Shield Diagnostics Key News & Latest Developments
    7.4 QuidelOrtho
        7.4.1 QuidelOrtho Company Summary
        7.4.2 QuidelOrtho Business Overview
        7.4.3 QuidelOrtho Disseminated Intravascular Coagulation Diagnosis Major Product Offerings
        7.4.4 QuidelOrtho Disseminated Intravascular Coagulation Diagnosis Revenue in Global Market (2018-2023)
        7.4.5 QuidelOrtho Key News & Latest Developments
    7.5 CTK Biotech
        7.5.1 CTK Biotech Company Summary
        7.5.2 CTK Biotech Business Overview
        7.5.3 CTK Biotech Disseminated Intravascular Coagulation Diagnosis Major Product Offerings
        7.5.4 CTK Biotech Disseminated Intravascular Coagulation Diagnosis Revenue in Global Market (2018-2023)
        7.5.5 CTK Biotech Key News & Latest Developments
    7.6 AccuBioTech Co
        7.6.1 AccuBioTech Co Company Summary
        7.6.2 AccuBioTech Co Business Overview
        7.6.3 AccuBioTech Co Disseminated Intravascular Coagulation Diagnosis Major Product Offerings
        7.6.4 AccuBioTech Co Disseminated Intravascular Coagulation Diagnosis Revenue in Global Market (2018-2023)
        7.6.5 AccuBioTech Co Key News & Latest Developments
    7.7 Getein Biotech
        7.7.1 Getein Biotech Company Summary
        7.7.2 Getein Biotech Business Overview
        7.7.3 Getein Biotech Disseminated Intravascular Coagulation Diagnosis Major Product Offerings
        7.7.4 Getein Biotech Disseminated Intravascular Coagulation Diagnosis Revenue in Global Market (2018-2023)
        7.7.5 Getein Biotech Key News & Latest Developments
    7.8 PHC Holdings Corporation
        7.8.1 PHC Holdings Corporation Company Summary
        7.8.2 PHC Holdings Corporation Business Overview
        7.8.3 PHC Holdings Corporation Disseminated Intravascular Coagulation Diagnosis Major Product Offerings
        7.8.4 PHC Holdings Corporation Disseminated Intravascular Coagulation Diagnosis Revenue in Global Market (2018-2023)
        7.8.5 PHC Holdings Corporation Key News & Latest Developments
    7.9 Siemens Healthineers
        7.9.1 Siemens Healthineers Company Summary
        7.9.2 Siemens Healthineers Business Overview
        7.9.3 Siemens Healthineers Disseminated Intravascular Coagulation Diagnosis Major Product Offerings
        7.9.4 Siemens Healthineers Disseminated Intravascular Coagulation Diagnosis Revenue in Global Market (2018-2023)
        7.9.5 Siemens Healthineers Key News & Latest Developments
    7.10 Eurolyser Diagnostica GmbH
        7.10.1 Eurolyser Diagnostica GmbH Company Summary
        7.10.2 Eurolyser Diagnostica GmbH Business Overview
        7.10.3 Eurolyser Diagnostica GmbH Disseminated Intravascular Coagulation Diagnosis Major Product Offerings
        7.10.4 Eurolyser Diagnostica GmbH Disseminated Intravascular Coagulation Diagnosis Revenue in Global Market (2018-2023)
        7.10.5 Eurolyser Diagnostica GmbH Key News & Latest Developments
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Disseminated Intravascular Coagulation Diagnosis Market, Global Outlook and Forecast 2023-2029

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?